Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 300,000 shares at $40.09 ($11.8M) on 2022-05-19, disclosed to the SEC on 2022-05-23.
Open-market sale of $11.8M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.09 | 26,304 | $1.1M | 8.9% |
| 2 | $40.09 | 26,304 | $1.1M | 8.9% |
| 3 | $39.28 | 123,696 | $4.9M | 41.1% |
| 4 | $39.28 | 123,696 | $4.9M | 41.1% |
| Total | $39.42 avg | 300,000 | $11.8M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |